Altimmune
(NASDAQ) ALT
Altimmune Financials at a Glance
Market Cap
$364.20M
Revenue (TTM)
$41.00K
Net Income (TTM)
$88.09M
EPS (TTM)
$-1.02
P/E Ratio
-2.76
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Price
$2.80
Volume
155,496
Open
$2.85
Price
$2.80
Volume
155,496
Open
$2.85
Previous Close
$2.80
Daily Range
$2.75 - $2.90
52-Week Range
$2.75 - $7.73
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Price
$2.80
Volume
155,496
Open
$2.85
Previous Close
$2.80
Daily Range
$2.75 - $2.90
52-Week Range
$2.75 - $7.73
ALT News
ALT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Altimmune
Industry
Biotechnology
Sector
Health CareEmployees
57
CEO
Vipin K. Garg, PhD
Website
www.altimmune.comHeadquarters
Gaithersburg, MD 20878, US
ALT Financials
Key Financial Metrics (TTM)
Gross Margin
-364%
Operating Margin
-2305%
Net Income Margin
-2149%
Return on Equity
-51%
Return on Capital
-36%
Return on Assets
-31%
Earnings Yield
-36.23%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$364.20M
Shares Outstanding
130.07M
Volume
155.50K
Short Interest
0.00%
Avg. Volume
4.10M
Financials (TTM)
Gross Profit
$71.00K
Operating Income
$94.49M
EBITDA
$94.49M
Operating Cash Flow
$67.53M
Capital Expenditure
$11.00K
Free Cash Flow
$67.55M
Cash & ST Invst.
$273.46M
Total Debt
$35.69M
Altimmune Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$26.00K
+420.0%
Gross Profit
$26.00K
+420.0%
Gross Margin
100.00%
N/A
Market Cap
$364.20M
N/A
Market Cap/Employee
$6.17M
N/A
Employees
59
N/A
Net Income
$27.36M
-18.0%
EBITDA
$28.89M
-24.8%
Quarterly Fundamentals
Net Cash
$237.77M
+82.6%
Accounts Receivable
$1.22M
-60.9%
Inventory
$0.00
N/A
Long Term Debt
$35.43M
+2427.2%
Short Term Debt
$256.00K
-8.2%
Return on Assets
-31.47%
N/A
Return on Invested Capital
-35.67%
N/A
Free Cash Flow
$19.45M
-6.5%
Operating Cash Flow
$19.45M
-6.5%